Filing Details

Accession Number:
0000914208-16-001202
Form Type:
13D Filing
Publication Date:
2016-11-29 13:02:54
Filed By:
Invesco Ltd.
Company:
Motif Bio Plc (NASDAQ:MTFB)
Filing Date:
2016-11-29
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Invesco Ltd 60,324,000 0 60,324,000 0 60,324,000 33.47%
Filing
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

SCHEDULE 13D

UNDER THE SECURITIES ACT OF 1934


Motif Bio plc
(Name of Issuer)

Ordinary Shares, par value £0.01 per share
(Title and Class of Securities)

619784101
(CUSIP Number)

 
Nancy Tomassone
Invesco Ltd.
1555 Peachtree Street, N.E., Suite 1800
Atlanta, Georgia 30309
Telephone number:  (404) 892-0896
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)




November 23, 2016
(Date of Event which Requires Filing of this Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box  ¨.

Note.  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7 for other parties to whom copies are to be sent.

*  The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(Continued on following pages)
(Page 1 of 5 Pages)


 
CUSIP No.  619784101
Schedule 13D
Page 2 of 5 Pages


1
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
Invesco Ltd.
IRS # 980557567
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                                                                                                                                (a)  ¨
(b)  ¨
3
SEC USE ONLY
 
4.
SOURCE OF FUNDS
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED     ¨
PURSUANT TO ITEMS  2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda
 
7
SOLE VOTING POWER
60,324,000
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
8
SHARED VOTING POWER
0
9
SOLE DISPOSITIVE POWER
60,324,000
 
10
SHARED DISPOSITIVE POWER
0
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
60,324,000
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
33.47%
14
TYPE OF REPORTING PERSON
HC, IA


Additionally, certain funds and accounts advised by Invesco Asset Management Limited owned a total of 27,600,000 Ordinary Shares prior to the IPO.  The funds and accounts that owned the Ordinary Shares and amounts are as follows:  Keystone Investment Trust: 4,416,000 Ordinary Shares; Perpetual Income and Growth Investment Trust: 16,560,000 Ordinary Shares and Invesco Perpetual UK Equity Investment Scheme 6,624,000 Ordinary Shares.  As of the date of this Statement, the Reporting Person beneficially owns a total of  60,324,000 Ordinary Shares, directly and indirectly through ADSs and warrants to purchase ADSs, which in the aggregate represent 33.47% of the Issuer’s Ordinary Shares based on 180,234,744 Ordinary Shares reported to be outstanding upon completion of the IPO as disclosed by the Issuer in its final prospectus filed with the Commission on November 21, 2016.
 
The Reporting Person disclaims beneficial ownership of the securities referred to in this Statement, and the filing of this Statement will not be construed as an admission that the Reporting Person is, for the purpose of Schedule 13D or 13G of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the beneficial owner of any securities covered by this Statement.
 
 
Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
None.
 
Item 7.  Material to be Filed As Exhibits.
 
None.
 
 
 
CUSIP No.  619784101
Schedule 13D
Page 5 of 5 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

 
Dated:  November 29, 2016
INVESCO LTD.

 

 
                               By:     /s/ Nancy Tomassone                                               
                             Name:  Nancy Tomassone
                             Title:    Global Assurance Officer